0001209191-17-049511.txt : 20170817
0001209191-17-049511.hdr.sgml : 20170817
20170817190142
ACCESSION NUMBER: 0001209191-17-049511
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170815
FILED AS OF DATE: 20170817
DATE AS OF CHANGE: 20170817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manning Paul B
CENTRAL INDEX KEY: 0001494695
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38135
FILM NUMBER: 171039819
MAIL ADDRESS:
STREET 1: 200 GARRETT STREET SUITE S
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PBM Capital Investments, LLC
CENTRAL INDEX KEY: 0001665309
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38135
FILM NUMBER: 171039818
BUSINESS ADDRESS:
STREET 1: 200 GARRETT STREET
STREET 2: SUITE S
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: 847-572-8280
MAIL ADDRESS:
STREET 1: C/O AVEXIS, INC., 2275 HALF DAY ROAD
STREET 2: SUITE 160
CITY: BANNOCKBURN
STATE: IL
ZIP: 60015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dova Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001685071
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813858961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2530 MERIDIAN PARKWAY
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919-806-4487
MAIL ADDRESS:
STREET 1: 2530 MERIDIAN PARKWAY
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27713
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-15
0
0001685071
Dova Pharmaceuticals, Inc.
DOVA
0001494695
Manning Paul B
200 GARRETT STREET, SUITE S
CHARLOTTESVILLE
VA
22902
1
0
1
0
0001665309
PBM Capital Investments, LLC
200 GARRETT STREET, SUITE S
CHARLOTTESVILLE
VA
22902
0
0
1
0
Common Stock
2017-08-15
4
P
0
13000
21.16
A
113000
D
Common Stock
2017-08-15
4
P
0
7870
22.39
A
120870
D
Common Stock
2017-08-16
4
P
0
3521
24.87
A
124391
D
Common Stock
2017-08-16
4
P
0
1379
25.62
A
125770
D
Common Stock
2017-08-16
4
P
0
100
26.81
A
125870
D
Common Stock
1783226
I
By LLC
Common Stock
12214953
I
By LLC
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.96 - $21.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
These shares are held by the Reporting Person together with his spouse as Joint Tenants with Right of Survivorship.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.00 - $22.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.41 - $25.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.41 - $26.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
These shares are held by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and, as such, has unilateral voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of the shares held by BKB except to the extent of his pecuniary interest therein, and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
These shares are held by PBM Capital Investments, LLC ("PBM"). The Reporting Person has the sole voting and investment power with respect to the shares held by PBM. The Reporting Person disclaims beneficial ownership of the shares held by PBM except to the extent of his pecuniary interest therein, and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
/s/Jason Saxe, Attorney-in-Fact
2017-08-17
/s/Jason Saxe, Attorney-in-Fact
2017-08-17